Soleno earnings release

Author: olhp

August undefined, 2024

WebGet the latest Soleno Therapeutics earnings report, revenues and EPS as well as upcoming SLNO earnings dates. ... Release Date Period End EPS / Forecast Revenue / Forecast; Aug …

Soleno Therapeutics Provides Corporate Update and Reports …

WebApr 14, 2024 · Earnings and Valuation. Earnings Growth. Earnings for Soleno Therapeutics are expected to grow in the coming year, from ($1.62) to ($0.47) per share. Price to … WebSoleno Therapeutics, Inc. (SLNO) latest earnings report: revenue, EPS, surprise, history, news and analysis. dash relefree es

SOLENO THERAPEUTICS INC : Press releases US8342031015

WebMar 31, 2024 · REDWOOD CITY, Calif., March 31, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company … WebApr 10, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Soleno Therapeutics stock is Buy based on the current 1 buy rating for SLNO. … WebFeb 24, 2024 · The Soleno Therapeutics Inc stock price gained 1.42% on the last trading day (Thursday, 2nd Feb 2024), rising from $2.82 to $2.86. During the last trading day the stock … dash refresh

Soleno Therapeutics Inc Earnings Date and Report - Investing.com …

Soleno earnings release

WebAug 10, 2024 · Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results REDWOOD CITY, Calif., August 10, 2024 - Soleno Therapeutics, Inc. … WebSoleno Therapeutics, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Did you know?

WebNov 13, 2024 · Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results Author PressReach Posted on November 13, 2024 Categories … WebMar 22, 2024 · The following information was filed by Soleno Therapeutics Inc (SLNO) on Tuesday, March 21, 2024 as an 8K 2.02 statement, which is an earnings press release …

WebFind real-time SLNO - Soleno Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. WebMar 21, 2024 · December 31, 2024 December 31, 2024 Assets Current assets Cash and cash equivalents $ 14,602 $ 21,304 Prepaid expenses and other current assets

WebSoleno Therapeutics earnings history information, presented by NextEarningsDate.com. Home; Calendar; History; Surprises This SLNO earnings history page last updated … WebApr 2, 2024 · Soleno Therapeutics (SLNO) will release its next earnings report on Apr 3, 2024. In the last quarter Soleno Therapeutics reported -$0.91 EPS in relation to -$0.76 …

WebMar 21, 2024 · Soleno Therapeutics Inc (SLNO) SEC Filing 8-K Material Event for the period ending Tuesday, March 21, 2024

WebMar 21, 2024 · Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare … dash referral swindonWebJun 2, 2024 · Q1 2024 Earnings Release 735.3 KB. Q1 2024 Earnings Presentation 2.2 MB. Earnings Call Script 192.7 KB. Q4 2024 StoneCo Ltd. Earnings Conference Call. March 11, … dash reload pageWeb2 days ago · SLNO: Soleno Therapeutics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. ... This is an estimated date of earnings … dash reliabilityWebView the latest Soleno Therapeutics Inc. (SLNO) stock price, news, historical charts, analyst ratings and financial information from WSJ. dash referral form somersetWebJan 26, 2024 · Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS), is currently being evaluated in a Phase 3 clinical development program. dash relayoutdataWebJan 13, 2024 · Earnings Estimate Revisions for Soleno Therapeutics, Inc. This company is expected to earn -$0.48 per share for the fiscal year ending December 2024, which represents a year-over-year change of 92%. bitesize exchange surfacesWebJul 27, 2024 · Soleno Therapeutics, Inc. SLNO will provide updates on its pipeline candidates when it releases second-quarter 2024 results. The company has a mixed track record, … bitesize everyday materials